Loading…

Increased Arterial Stiffness in Chronic Thromboembolic Pulmonary Hypertension Was Improved with Riociguat and Balloon Pulmonary Angioplasty: A Case Report

The role of arterial stiffness in the pathophysiology of chronic thromboembolic pulmonary hypertension (CTEPH) is unclear. The cardio-ankle vascular index (CAVI) is a novel arterial stiffness index reflecting stiffness of the arterial tree from the origin of the aorta to the ankle, independent from...

Full description

Saved in:
Bibliographic Details
Published in:International medical case reports journal 2021-03, Vol.14, p.191-197
Main Authors: Sato, Shuji, Shimizu, Kazuhiro, Ito, Takuro, Tsubono, Masakazu, Ogawa, Akihiro, Sasaki, Takeshi, Takahashi, Mao, Noro, Mahito, Shirai, Kohji
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c4617-44313a3dfe3a5dc5afad41d801f672f19173ae0eb6844070bc2494ada53f77113
cites cdi_FETCH-LOGICAL-c4617-44313a3dfe3a5dc5afad41d801f672f19173ae0eb6844070bc2494ada53f77113
container_end_page 197
container_issue
container_start_page 191
container_title International medical case reports journal
container_volume 14
creator Sato, Shuji
Shimizu, Kazuhiro
Ito, Takuro
Tsubono, Masakazu
Ogawa, Akihiro
Sasaki, Takeshi
Takahashi, Mao
Noro, Mahito
Shirai, Kohji
description The role of arterial stiffness in the pathophysiology of chronic thromboembolic pulmonary hypertension (CTEPH) is unclear. The cardio-ankle vascular index (CAVI) is a novel arterial stiffness index reflecting stiffness of the arterial tree from the origin of the aorta to the ankle, independent from blood pressure at the time of measurement. CAVI reflects functional stiffness, due to smooth muscle cell contraction or relaxation, and organic stiffness, due to atherosclerosis. Here, we report the case of a patient with an increased CAVI due to CTEPH and the improvement after riociguat administration and balloon pulmonary angioplasty (BPA). A 65-year-old man suffered from dyspnea on exertion, and he was diagnosed with distal CTEPH. The mean pulmonary artery pressure (mPAP) was 51 mmHg, and the initial CAVI was 10.0, which is high for patient's age. In addition to right ventricular dysfunction, left ventricular dysfunction was observed as reduced global longitudinal strain (GLS-LV). After riociguat administration, CAVI decreased to 9.1 and GLS-LV improved from -10.3% to -17.3%, although pulmonary hypertension remained (mPAP 41 mmHg). Subsequently, a total of five BPA sessions were performed. Six months after the final BPA, mPAP decreased to 19 mmHg and GLS-LV improved to 19.3%. The patient was symptom free and his 6-minute walk distance improved from 322 m to 510 m. CAVI markedly decreased to 5.8, which is extremely low for his age. These observations suggested that arterial stiffness as measured by CAVI was increased in CTEPH, potentially deteriorating cardiac function because of enhanced afterload. The mechanism of the increase of CAVI in this case of CTEPH was obscure; however, riociguat administration and BPA might improve the pathophysiology of CTEPH partly by decreasing CAVI.
doi_str_mv 10.2147/IMCRJ.S303997
format article
fullrecord <record><control><sourceid>gale_doaj_</sourceid><recordid>TN_cdi_doaj_primary_oai_doaj_org_article_7162d75380cb4fd09556b63bcd2c4f01</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A658252433</galeid><doaj_id>oai_doaj_org_article_7162d75380cb4fd09556b63bcd2c4f01</doaj_id><sourcerecordid>A658252433</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4617-44313a3dfe3a5dc5afad41d801f672f19173ae0eb6844070bc2494ada53f77113</originalsourceid><addsrcrecordid>eNptUl2PEyEUnRiNu1n30VdDYuJbKwwwzPhg0m3UrVmj6a7RN8Lw0dIwMMLMmv4Vf63stu62iRBy4XLOyb1wiuIlgtMSEfZ28WW-_Dy9xhA3DXtSnCLEmgki5c-nB_uT4jylDcwDNyVD7HlxgnFdkgqS0-LPwsuoRdIKzOKgoxUOXA_WGK9TAtaD-ToGbyW4ybFrg87L5eO30XXBi7gFl9teZ6ZPNnjwQySw6PoYbrPgbzuswdIGaVejGIDwClwI50LGPdJnfmVD70Qatu_ADMxzKWCp-xCHF8UzI1zS5_t4Vnz_-OFmfjm5-vppMZ9dTSSpEJsQghEWWBmNBVWSCiMUQaqGyFSsNKhBDAsNdVvVhEAGW1mShgglKDaMIYTPisVOVwWx4X20Xa6LB2H5fSLEFRdxsNJpzlBVKkZxDWVLjIINpVVb4VaqUhID77Te77T6se20ktoPUbgj0eMbb9d8FW55LremtMkCr_cCMfwadRr4JozR5_55SRGmFDKKHlErkauy3oQsJjubJJ9VtC5pSTDOqOl_UHkq3VkZvDY2548Ibw4Iay3csE7BjUP-2nQMnOyAMoaUojYPHSLI75zJ753J987M-FeHz_KA_udD_Bf5Xt8c</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2513550751</pqid></control><display><type>article</type><title>Increased Arterial Stiffness in Chronic Thromboembolic Pulmonary Hypertension Was Improved with Riociguat and Balloon Pulmonary Angioplasty: A Case Report</title><source>Publicly Available Content Database (Proquest) (PQ_SDU_P3)</source><source>PubMed Central</source><creator>Sato, Shuji ; Shimizu, Kazuhiro ; Ito, Takuro ; Tsubono, Masakazu ; Ogawa, Akihiro ; Sasaki, Takeshi ; Takahashi, Mao ; Noro, Mahito ; Shirai, Kohji</creator><creatorcontrib>Sato, Shuji ; Shimizu, Kazuhiro ; Ito, Takuro ; Tsubono, Masakazu ; Ogawa, Akihiro ; Sasaki, Takeshi ; Takahashi, Mao ; Noro, Mahito ; Shirai, Kohji</creatorcontrib><description>The role of arterial stiffness in the pathophysiology of chronic thromboembolic pulmonary hypertension (CTEPH) is unclear. The cardio-ankle vascular index (CAVI) is a novel arterial stiffness index reflecting stiffness of the arterial tree from the origin of the aorta to the ankle, independent from blood pressure at the time of measurement. CAVI reflects functional stiffness, due to smooth muscle cell contraction or relaxation, and organic stiffness, due to atherosclerosis. Here, we report the case of a patient with an increased CAVI due to CTEPH and the improvement after riociguat administration and balloon pulmonary angioplasty (BPA). A 65-year-old man suffered from dyspnea on exertion, and he was diagnosed with distal CTEPH. The mean pulmonary artery pressure (mPAP) was 51 mmHg, and the initial CAVI was 10.0, which is high for patient's age. In addition to right ventricular dysfunction, left ventricular dysfunction was observed as reduced global longitudinal strain (GLS-LV). After riociguat administration, CAVI decreased to 9.1 and GLS-LV improved from -10.3% to -17.3%, although pulmonary hypertension remained (mPAP 41 mmHg). Subsequently, a total of five BPA sessions were performed. Six months after the final BPA, mPAP decreased to 19 mmHg and GLS-LV improved to 19.3%. The patient was symptom free and his 6-minute walk distance improved from 322 m to 510 m. CAVI markedly decreased to 5.8, which is extremely low for his age. These observations suggested that arterial stiffness as measured by CAVI was increased in CTEPH, potentially deteriorating cardiac function because of enhanced afterload. The mechanism of the increase of CAVI in this case of CTEPH was obscure; however, riociguat administration and BPA might improve the pathophysiology of CTEPH partly by decreasing CAVI.</description><identifier>ISSN: 1179-142X</identifier><identifier>EISSN: 1179-142X</identifier><identifier>DOI: 10.2147/IMCRJ.S303997</identifier><identifier>PMID: 33824604</identifier><language>eng</language><publisher>New Zealand: Dove Medical Press Limited</publisher><subject>Angioplasty ; Ankle ; Anticoagulants ; arterial stiffness ; Atherosclerosis ; Blood pressure ; cardio-ankle vascular index ; Case Report ; Case reports ; Cholesterol ; chronic thromboembolic pulmonary hypertension ; Dyspnea ; Health aspects ; Heart ; Hypotension ; Medical imaging ; Pathophysiology ; Patients ; Peptides ; Pulmonary arteries ; Pulmonary hypertension ; Scintigraphy ; Smooth muscle ; Thromboembolism ; Veins &amp; arteries ; ventricular afterload</subject><ispartof>International medical case reports journal, 2021-03, Vol.14, p.191-197</ispartof><rights>2021 Sato et al.</rights><rights>COPYRIGHT 2021 Dove Medical Press Limited</rights><rights>2021. This work is licensed under https://creativecommons.org/licenses/by-nc/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>2021 Sato et al. 2021 Sato et al.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4617-44313a3dfe3a5dc5afad41d801f672f19173ae0eb6844070bc2494ada53f77113</citedby><cites>FETCH-LOGICAL-c4617-44313a3dfe3a5dc5afad41d801f672f19173ae0eb6844070bc2494ada53f77113</cites><orcidid>0000-0002-6386-8670 ; 0000-0003-2808-2020 ; 0000-0001-9896-0939</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.proquest.com/docview/2513550751/fulltextPDF?pq-origsite=primo$$EPDF$$P50$$Gproquest$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.proquest.com/docview/2513550751?pq-origsite=primo$$EHTML$$P50$$Gproquest$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,25753,27924,27925,37012,44590,53791,53793,75126</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/33824604$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Sato, Shuji</creatorcontrib><creatorcontrib>Shimizu, Kazuhiro</creatorcontrib><creatorcontrib>Ito, Takuro</creatorcontrib><creatorcontrib>Tsubono, Masakazu</creatorcontrib><creatorcontrib>Ogawa, Akihiro</creatorcontrib><creatorcontrib>Sasaki, Takeshi</creatorcontrib><creatorcontrib>Takahashi, Mao</creatorcontrib><creatorcontrib>Noro, Mahito</creatorcontrib><creatorcontrib>Shirai, Kohji</creatorcontrib><title>Increased Arterial Stiffness in Chronic Thromboembolic Pulmonary Hypertension Was Improved with Riociguat and Balloon Pulmonary Angioplasty: A Case Report</title><title>International medical case reports journal</title><addtitle>Int Med Case Rep J</addtitle><description>The role of arterial stiffness in the pathophysiology of chronic thromboembolic pulmonary hypertension (CTEPH) is unclear. The cardio-ankle vascular index (CAVI) is a novel arterial stiffness index reflecting stiffness of the arterial tree from the origin of the aorta to the ankle, independent from blood pressure at the time of measurement. CAVI reflects functional stiffness, due to smooth muscle cell contraction or relaxation, and organic stiffness, due to atherosclerosis. Here, we report the case of a patient with an increased CAVI due to CTEPH and the improvement after riociguat administration and balloon pulmonary angioplasty (BPA). A 65-year-old man suffered from dyspnea on exertion, and he was diagnosed with distal CTEPH. The mean pulmonary artery pressure (mPAP) was 51 mmHg, and the initial CAVI was 10.0, which is high for patient's age. In addition to right ventricular dysfunction, left ventricular dysfunction was observed as reduced global longitudinal strain (GLS-LV). After riociguat administration, CAVI decreased to 9.1 and GLS-LV improved from -10.3% to -17.3%, although pulmonary hypertension remained (mPAP 41 mmHg). Subsequently, a total of five BPA sessions were performed. Six months after the final BPA, mPAP decreased to 19 mmHg and GLS-LV improved to 19.3%. The patient was symptom free and his 6-minute walk distance improved from 322 m to 510 m. CAVI markedly decreased to 5.8, which is extremely low for his age. These observations suggested that arterial stiffness as measured by CAVI was increased in CTEPH, potentially deteriorating cardiac function because of enhanced afterload. The mechanism of the increase of CAVI in this case of CTEPH was obscure; however, riociguat administration and BPA might improve the pathophysiology of CTEPH partly by decreasing CAVI.</description><subject>Angioplasty</subject><subject>Ankle</subject><subject>Anticoagulants</subject><subject>arterial stiffness</subject><subject>Atherosclerosis</subject><subject>Blood pressure</subject><subject>cardio-ankle vascular index</subject><subject>Case Report</subject><subject>Case reports</subject><subject>Cholesterol</subject><subject>chronic thromboembolic pulmonary hypertension</subject><subject>Dyspnea</subject><subject>Health aspects</subject><subject>Heart</subject><subject>Hypotension</subject><subject>Medical imaging</subject><subject>Pathophysiology</subject><subject>Patients</subject><subject>Peptides</subject><subject>Pulmonary arteries</subject><subject>Pulmonary hypertension</subject><subject>Scintigraphy</subject><subject>Smooth muscle</subject><subject>Thromboembolism</subject><subject>Veins &amp; arteries</subject><subject>ventricular afterload</subject><issn>1179-142X</issn><issn>1179-142X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><sourceid>PIMPY</sourceid><sourceid>DOA</sourceid><recordid>eNptUl2PEyEUnRiNu1n30VdDYuJbKwwwzPhg0m3UrVmj6a7RN8Lw0dIwMMLMmv4Vf63stu62iRBy4XLOyb1wiuIlgtMSEfZ28WW-_Dy9xhA3DXtSnCLEmgki5c-nB_uT4jylDcwDNyVD7HlxgnFdkgqS0-LPwsuoRdIKzOKgoxUOXA_WGK9TAtaD-ToGbyW4ybFrg87L5eO30XXBi7gFl9teZ6ZPNnjwQySw6PoYbrPgbzuswdIGaVejGIDwClwI50LGPdJnfmVD70Qatu_ADMxzKWCp-xCHF8UzI1zS5_t4Vnz_-OFmfjm5-vppMZ9dTSSpEJsQghEWWBmNBVWSCiMUQaqGyFSsNKhBDAsNdVvVhEAGW1mShgglKDaMIYTPisVOVwWx4X20Xa6LB2H5fSLEFRdxsNJpzlBVKkZxDWVLjIINpVVb4VaqUhID77Te77T6se20ktoPUbgj0eMbb9d8FW55LremtMkCr_cCMfwadRr4JozR5_55SRGmFDKKHlErkauy3oQsJjubJJ9VtC5pSTDOqOl_UHkq3VkZvDY2548Ibw4Iay3csE7BjUP-2nQMnOyAMoaUojYPHSLI75zJ753J987M-FeHz_KA_udD_Bf5Xt8c</recordid><startdate>20210331</startdate><enddate>20210331</enddate><creator>Sato, Shuji</creator><creator>Shimizu, Kazuhiro</creator><creator>Ito, Takuro</creator><creator>Tsubono, Masakazu</creator><creator>Ogawa, Akihiro</creator><creator>Sasaki, Takeshi</creator><creator>Takahashi, Mao</creator><creator>Noro, Mahito</creator><creator>Shirai, Kohji</creator><general>Dove Medical Press Limited</general><general>Taylor &amp; Francis Ltd</general><general>Dove</general><general>Dove Medical Press</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>K9.</scope><scope>M0S</scope><scope>M2O</scope><scope>MBDVC</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>Q9U</scope><scope>5PM</scope><scope>DOA</scope><orcidid>https://orcid.org/0000-0002-6386-8670</orcidid><orcidid>https://orcid.org/0000-0003-2808-2020</orcidid><orcidid>https://orcid.org/0000-0001-9896-0939</orcidid></search><sort><creationdate>20210331</creationdate><title>Increased Arterial Stiffness in Chronic Thromboembolic Pulmonary Hypertension Was Improved with Riociguat and Balloon Pulmonary Angioplasty: A Case Report</title><author>Sato, Shuji ; Shimizu, Kazuhiro ; Ito, Takuro ; Tsubono, Masakazu ; Ogawa, Akihiro ; Sasaki, Takeshi ; Takahashi, Mao ; Noro, Mahito ; Shirai, Kohji</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4617-44313a3dfe3a5dc5afad41d801f672f19173ae0eb6844070bc2494ada53f77113</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>Angioplasty</topic><topic>Ankle</topic><topic>Anticoagulants</topic><topic>arterial stiffness</topic><topic>Atherosclerosis</topic><topic>Blood pressure</topic><topic>cardio-ankle vascular index</topic><topic>Case Report</topic><topic>Case reports</topic><topic>Cholesterol</topic><topic>chronic thromboembolic pulmonary hypertension</topic><topic>Dyspnea</topic><topic>Health aspects</topic><topic>Heart</topic><topic>Hypotension</topic><topic>Medical imaging</topic><topic>Pathophysiology</topic><topic>Patients</topic><topic>Peptides</topic><topic>Pulmonary arteries</topic><topic>Pulmonary hypertension</topic><topic>Scintigraphy</topic><topic>Smooth muscle</topic><topic>Thromboembolism</topic><topic>Veins &amp; arteries</topic><topic>ventricular afterload</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Sato, Shuji</creatorcontrib><creatorcontrib>Shimizu, Kazuhiro</creatorcontrib><creatorcontrib>Ito, Takuro</creatorcontrib><creatorcontrib>Tsubono, Masakazu</creatorcontrib><creatorcontrib>Ogawa, Akihiro</creatorcontrib><creatorcontrib>Sasaki, Takeshi</creatorcontrib><creatorcontrib>Takahashi, Mao</creatorcontrib><creatorcontrib>Noro, Mahito</creatorcontrib><creatorcontrib>Shirai, Kohji</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health &amp; Medical Collection (Proquest)</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>ProQuest research library</collection><collection>Research Library (Corporate)</collection><collection>Publicly Available Content Database (Proquest) (PQ_SDU_P3)</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest Central Basic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>International medical case reports journal</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Sato, Shuji</au><au>Shimizu, Kazuhiro</au><au>Ito, Takuro</au><au>Tsubono, Masakazu</au><au>Ogawa, Akihiro</au><au>Sasaki, Takeshi</au><au>Takahashi, Mao</au><au>Noro, Mahito</au><au>Shirai, Kohji</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Increased Arterial Stiffness in Chronic Thromboembolic Pulmonary Hypertension Was Improved with Riociguat and Balloon Pulmonary Angioplasty: A Case Report</atitle><jtitle>International medical case reports journal</jtitle><addtitle>Int Med Case Rep J</addtitle><date>2021-03-31</date><risdate>2021</risdate><volume>14</volume><spage>191</spage><epage>197</epage><pages>191-197</pages><issn>1179-142X</issn><eissn>1179-142X</eissn><abstract>The role of arterial stiffness in the pathophysiology of chronic thromboembolic pulmonary hypertension (CTEPH) is unclear. The cardio-ankle vascular index (CAVI) is a novel arterial stiffness index reflecting stiffness of the arterial tree from the origin of the aorta to the ankle, independent from blood pressure at the time of measurement. CAVI reflects functional stiffness, due to smooth muscle cell contraction or relaxation, and organic stiffness, due to atherosclerosis. Here, we report the case of a patient with an increased CAVI due to CTEPH and the improvement after riociguat administration and balloon pulmonary angioplasty (BPA). A 65-year-old man suffered from dyspnea on exertion, and he was diagnosed with distal CTEPH. The mean pulmonary artery pressure (mPAP) was 51 mmHg, and the initial CAVI was 10.0, which is high for patient's age. In addition to right ventricular dysfunction, left ventricular dysfunction was observed as reduced global longitudinal strain (GLS-LV). After riociguat administration, CAVI decreased to 9.1 and GLS-LV improved from -10.3% to -17.3%, although pulmonary hypertension remained (mPAP 41 mmHg). Subsequently, a total of five BPA sessions were performed. Six months after the final BPA, mPAP decreased to 19 mmHg and GLS-LV improved to 19.3%. The patient was symptom free and his 6-minute walk distance improved from 322 m to 510 m. CAVI markedly decreased to 5.8, which is extremely low for his age. These observations suggested that arterial stiffness as measured by CAVI was increased in CTEPH, potentially deteriorating cardiac function because of enhanced afterload. The mechanism of the increase of CAVI in this case of CTEPH was obscure; however, riociguat administration and BPA might improve the pathophysiology of CTEPH partly by decreasing CAVI.</abstract><cop>New Zealand</cop><pub>Dove Medical Press Limited</pub><pmid>33824604</pmid><doi>10.2147/IMCRJ.S303997</doi><tpages>7</tpages><orcidid>https://orcid.org/0000-0002-6386-8670</orcidid><orcidid>https://orcid.org/0000-0003-2808-2020</orcidid><orcidid>https://orcid.org/0000-0001-9896-0939</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1179-142X
ispartof International medical case reports journal, 2021-03, Vol.14, p.191-197
issn 1179-142X
1179-142X
language eng
recordid cdi_doaj_primary_oai_doaj_org_article_7162d75380cb4fd09556b63bcd2c4f01
source Publicly Available Content Database (Proquest) (PQ_SDU_P3); PubMed Central
subjects Angioplasty
Ankle
Anticoagulants
arterial stiffness
Atherosclerosis
Blood pressure
cardio-ankle vascular index
Case Report
Case reports
Cholesterol
chronic thromboembolic pulmonary hypertension
Dyspnea
Health aspects
Heart
Hypotension
Medical imaging
Pathophysiology
Patients
Peptides
Pulmonary arteries
Pulmonary hypertension
Scintigraphy
Smooth muscle
Thromboembolism
Veins & arteries
ventricular afterload
title Increased Arterial Stiffness in Chronic Thromboembolic Pulmonary Hypertension Was Improved with Riociguat and Balloon Pulmonary Angioplasty: A Case Report
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-06T17%3A09%3A50IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_doaj_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Increased%20Arterial%20Stiffness%20in%20Chronic%20Thromboembolic%20Pulmonary%20Hypertension%20Was%20Improved%20with%20Riociguat%20and%20Balloon%20Pulmonary%20Angioplasty:%20A%20Case%20Report&rft.jtitle=International%20medical%20case%20reports%20journal&rft.au=Sato,%20Shuji&rft.date=2021-03-31&rft.volume=14&rft.spage=191&rft.epage=197&rft.pages=191-197&rft.issn=1179-142X&rft.eissn=1179-142X&rft_id=info:doi/10.2147/IMCRJ.S303997&rft_dat=%3Cgale_doaj_%3EA658252433%3C/gale_doaj_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c4617-44313a3dfe3a5dc5afad41d801f672f19173ae0eb6844070bc2494ada53f77113%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2513550751&rft_id=info:pmid/33824604&rft_galeid=A658252433&rfr_iscdi=true